Abstract:Atherosclerosis is a chronic artery disease characterized by plaque formation and vascular inflammation, eventually leading to myocardial infarction and stroke. Innate immunity plays an irreplaceable role in the vascular inflammatory response triggered by chronic infection. Periodontitis is a common chronic disorder that involves oral microbe-related inflammatory bone loss and local destruction of the periodontal ligament and is a risk factor for atherosclerosis. Periodontal pathogens contain numerous pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide, CpG DNA, and Peptidoglycan, that initiate the inflammatory response of the innate immunity depending on the recognition of pattern-recognition receptors (PRRs) of host cells. The immune-inflammatory response and destruction of the periodontal tissue will produce a large number of damage-associated molecular patterns (DAMPs) such as neutrophil extracellular traps (NETs), high mobility group box 1 (HMGB1), alarmins (S100 protein), and which can further affect the progression of atherosclerosis. Molecular patterns have recently become the therapeutic targets for inflammatory disease, including blocking the interaction between molecular patterns and PRRs and controlling the related signal transduction pathway. This review summarized the research progress of some representative PAMPs and DAMPs as the molecular pathological mechanism bridging periodontitis and atherosclerosis. We also discussed possible ways to prevent serious cardiovascular events in patients with periodontitis and atherosclerosis by targeting molecular patterns.

DAMPs and DAMP-sensing receptors in inflammation and diseases

DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways

NMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury

DAMP-sensing Receptors in Sterile Inflammation and Inflammatory Diseases

Old and New Damage‐associated Molecular Patterns (damps) in Autoimmune Diseases

Metabolite-derived Damage-Associated Molecular Patterns in Immunological Diseases.

Damage-Associated Molecular Patterns in Inflammatory Diseases

DAMPs in immunosenescence and cancer

Lysophospholipid Receptors, As Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation-Novel Paradigm and Therapeutic Potential

Activation and Pharmacological Regulation of Inflammasomes

Metabolism-Associated Molecular Patterns (MAMPs)

Damage-Associated Molecular Patterns and Systemic Signaling

PAMPs and DAMPs as the Bridge Between Periodontitis and Atherosclerosis: The Potential Therapeutic Targets

Mitochondrial Damage-Associated Molecular Patterns in Chronic Obstructive Pulmonary Disease: Pathogenetic Mechanism and Therapeutic Target.

Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders

Damage-Associated Molecular Patterns and Pattern Recognition Receptors in the Podocyte

Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets

Damage-associated molecular patterns in viral infection: potential therapeutic targets

Innate recognition of microbial-derived signals in immunity and inflammation

Lysophospholipids and Their Receptors Serve As Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury.

The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases